News

EP PerMed - New Fast Track and Venture Creator Programmes

Published on | 1 month ago

Programmes Health

The European Partnership for Personalised Medicine (EP PerMed) introduces two new opportunities for start-ups, researchers, and early-stage teams working on cutting-edge solutions in personalised medicine. These programmes aim to accelerate the development, validation, and market readiness of transformative innovations that enhance patient care:

  • Fast Track Validation Programme 
    Designed to address a critical bottleneck in personalised medicine development, this programme supports validation studies to elevate projects to higher technological and market readiness levels.
    Join the info webinar on 21 January 2025 here

  • Ventior Creation Programme
    This programme empowers early-stage ventures or teams in personalised medicine by bridging the gap between innovation and commercialisation through mentoring, business model development, and customer discovery.
    Join the info webinar on 28 January 2025 here

Submission deadline is 13 March 2025

Find out more
about both calls and how to apply on the EP PerMed website.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1523 articles available search in articles 

Testimonial

image of ROOT - Rolling Out OSNMA for the secure synchronization of Telecom networks

ROOT - Rolling Out OSNMA for the secure synchronization of Telecom networks

The ROOT project obtained funding under Horizon 2020 topic ‘EGNSS applications fostering societal resilience and protecting the environment’. The project, which ran from November 2020 to July 2022,  aimed to demonstrate the benefit of Galileo OSNMA signal to increase the robustness of critical telecom infrastructures.

The Flanders-based company Septentrio contributed substantially to completing this objective together with the other ROOT partners. The results of the project partially close a gap in the security of telecommunication networks dependent on satellite-derived time, with indirect benefits in curbing illegal attempts to disrupt network services.